Olmesartan medoxomil and hydrochlorothiazide
Olmesartan Medoxomil and Hydrochlorothiazide is a prescription medication combining an angiotensin II receptor blocker and a diuretic to treat high blood pressure. Available as oral tablets in strengths like 12.5mg/20mg, 12.5mg/40mg, and 25mg/40mg, it's taken by mouth. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Olmesartan Medoxomil and Hydrochlorothiazide is a prescription medication combining an angiotensin II receptor blocker and a diuretic to treat high blood pressure. Available as oral tablets in strengths like 12.5mg/20mg, 12.5mg/40mg, and 25mg/40mg, it's taken by mouth. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Olmesartan medoxomil and hydrochlorothiazide", "mediaType": "text/html", "description": " Access the FDA dataset for Olmesartan medoxomil and hydrochlorothiazide — ANDA 207804 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207804" } ] |
| identifier | ANDA207804 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "fda", "health-care", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Olmesartan medoxomil and hydrochlorothiazide |
